Smiths Group PLC Statement regarding Smiths Medical (4369P)
May 29 2018 - 1:01AM
UK Regulatory
TIDMSMIN
RNS Number : 4369P
Smiths Group PLC
29 May 2018
News Release
London, 27 May 2018
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN, INTO OR FROM
ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE
RELEVANT LAWS OF SUCH JURISDICTION
Sunday 27 May 2018
Smiths Group plc ("Smiths")
Statement regarding Smiths Medical
Smiths notes the press speculation regarding discussions
involving its Smiths Medical business and confirms that it is in
very early stage discussions about a potential combination of its
medical division with ICU Medical, Inc. (NASDAQ: ICUI).
The Board of Smiths routinely reviews all options for the
Group's portfolio of businesses to maximise value for Smiths
shareholders.
There can be no certainty that a transaction will be
concluded.
END
Contact details
Investor enquiries
Jemma Spalton, Smiths Marion Le Bot, Smiths
Group Group
+44 (0)20 7004 1637 +44 (0)20 7004 1672
+44 (0)78 6739 0350 +44 (0)75 8315 4386
jemma.spalton@smiths.com marion.lebot@smiths.com
Media enquiries
Deborah Scott, FTI Consulting Alex Le May, FTI Consulting
+44 (0)20 3727 1459 +44 (0)20 3727 1308
+44 (0)797 953 7449 +44 (0)7702 443 312
smiths@fticonsulting.com smiths@fticonsulting.com
About Smiths Group
Smiths Group is a global technology company listed on the London
Stock Exchange (SMIN) and operates a sponsored level one ADR
programme (SMGZY). A world leader in the practical application of
advanced technologies, Smiths Group delivers products and services
for the medical technology, security & defence, general
industrial, oil & gas, and space & aerospace markets
worldwide. Smiths Group employs c.22,000 colleagues in over 50
countries. For more information visit www.smiths.com.
About Smiths Medical
Smiths Medical is a leading supplier of specialised medical
devices and equipment for global markets, focusing on the
medication delivery, vital care and safety devices market segments.
For more information visit www.smiths-medical.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
STRAPMLTMBJTBMP
(END) Dow Jones Newswires
May 29, 2018 02:01 ET (06:01 GMT)
Smiths (LSE:SMIN)
Historical Stock Chart
From Apr 2024 to May 2024
Smiths (LSE:SMIN)
Historical Stock Chart
From May 2023 to May 2024